Skip to main content
Journal ArticleOPEN ACCESS

Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill

  • Deane A
  • Fraser R
  • Horowitz M
  • et al.
Critical Care (2009) 13(Suppl 1) P126
DOI: 10.1186/cc7290
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The purpose of this study was to determine the effects of exogenous glucagon-like peptide 1 (GLP-1) on the glycaemic response to enteral nutrition in nondiabetic, critically ill patients.

Cite

CITATION STYLE

APA

Deane, A., Fraser, R., Horowitz, M., Burgstad, C., Besanko, L., Finnis, M., … Chapman, M. (2009). Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill. Critical Care, 13(Suppl 1), P126. https://doi.org/10.1186/cc7290

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free